Jin JH et al. [96] found that the mean concentrations of both adiponectin and leptin in ovarian cancer patients were lower than in the control group (8.25 vs. 11.44 μg/mL; p = 0.026, respectively) (7.09 vs. 15.4 ng/mL; p = 0.001). This evidence concerns the gene ADIPOQ and ovarian carcinoma.